Apyx Medical CorporationAPYXNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank79
5Y CAGR+33.7%
Year-over-Year Change
Year-over-year operating cash flow growth rate
5Y CAGR
+33.7%/yr
Long-term compound
Percentile
P79
Within normal range
vs 5Y Ago
4.3x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 55.67% |
| 2024 | -243.82% |
| 2023 | 74.12% |
| 2022 | -94.09% |
| 2021 | 34.96% |
| 2020 | 13.04% |
| 2019 | 12.07% |
| 2018 | -467.25% |
| 2017 | -30.56% |
| 2016 | 50.97% |